HP
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for HP, covering 2022-01-05 to 2026-03-06. Get the full timeline:
Most recent: Clinical Trial Update: A Study on the Efficacy and Safety of Switching Between Two Targeted Strategies, HP+Chemotherapy and HPy+Chemotherapy, After Treatment Progression in HER-2 Positive Advanced or Metastatic Breast Cancer